ArticleBMC cancer2016

Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by N-acetylcysteine.

Andrea Orue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.